Based on the positive Phase 1 results and approval from Canadian regulatory authorities, Medicago has decided to commence the Phase 2/3 clinical trial with ... Nov 13
Plant based formulations with adjuvants from Medicago enters trial... Jul 18
GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine ... Jul 09
-Advertisements-